We performed a systematic review on the efficacy, effectiveness and safety of HPV vaccination in males of any age. This study aimed to compare among HIV-1 seropositive and HIV-seronegative Ghanaian women: (1) the prevalence, genotype distribution and risk factors associated with cervical HPV infection; and (2) the prevalence and risk factors associated with abnormal cervical cytology. There’s no evidence that the HPV vaccine causes serious harm, but an investigation shows the trials weren’t designed to properly assess safety. Since licensure in 2006, over 270 million doses of HPV vaccines have been distributed. Retrieved May 21, … Dec 17, 2017 Cover Story.
Extract from report of GACVS meeting of 7-8 June 2017, published in the WHO Weekly Epidemiological Record of 14 July 2017 . Human papillomavirus (HPV) vaccination is safe and effective in preventing cervical cancer in females.
Study Reveals 11 Million Men Are Infected With Cancer-Linked HPV and Don't Know It Oct. 18, 2017 01:46. GACVS first reviewed the safety data in 2007, 12 and subsequently in 2008, 13 2009, 14 2013, 15 2014, 16 and 2015.
There is limited data in Ghana on the epidemiology of HPV and cervical neoplasia and their associations with HIV. Human papillomavirus (HPV) is the most common sexually transmitted infection among humans, and represents a well-established cause of cervical cancer in females and a significant factor in the development of anogenital, head, and neck cancers .A number of investigations have found that HPV infection may also be transmitted by nonsexual routes , as HPV DNA has been detected in blood … ScienceDaily. As HPV infections can also induce cancers of the anus, penis and oral cavity, male vaccination is also advocated, but systematic reviews on efficacy and safety in males are lacking.
HPV vaccine could drastically reduce cervical and other cancers globally. University of New Mexico Comprehensive Cancer Center. (2017, June 12).